Lonza | LONN - Ebitda

Stock Price
510.80
Daily Change
-1.40 -0.27%
Monthly
2.43%
Yearly
-2.03%
Q2 Forecast
499.29

Lonza reported CHF1.01B in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Akzo Nobel EUR 385M 8M Sep/2025
Alcon AG USD 317M 337M Dec/2025
Almirall EUR 114.07M 60.37M Dec/2025
AstraZeneca USD 5.23B 272M Sep/2025
BASF EUR 1.54B 228M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Beiersdorf EUR 984M 147M Jun/2025
Covestro EUR 242M 24M Sep/2025
Demant DKK 2.76B 165M Dec/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Geberit CHF 177.6M 58.4M Dec/2025
Genmab DKK 186M 291M Dec/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GN Store Nord DKK 627M 106M Dec/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 325M 52M Jun/2024
Merck EUR 1.44B 263M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
Sika AG CHF 994.3M 76.1M Dec/2025
Smith & Nephew USD 796M 139M Dec/2025
Solvay EUR 169M 63M Dec/2025
UCB EUR 1.6B 570M Dec/2025